- Published on
Emergency and Acute Medicine: Scorpion Sting (Envenomation)
Scorpion envenomation is a potentially serious condition caused by injection of neurotoxic venom, which affects sodium channels and leads to prolonged neuronal firing. This results in widespread stimulation of autonomic, somatic, and cranial nerves. Symptoms typically begin within minutes of the sting and can last from several hours up to 72 hours. The severity of illness varies depending on the species and the patient, with children at significantly higher risk of severe toxicity and complications.
The most clinically significant species in North America is Centruroides sculpturatus (bark scorpion), found in parts of the southern United States, Mexico, and Central America. Globally, many dangerous species exist across Asia, Africa, the Middle East, and South America. Pediatric patients are especially vulnerable due to lower body mass and may present with symptoms that mimic seizures, poisoning, or central nervous system infections.
Clinical manifestations develop rapidly, usually peaking within 1–2 hours. Local findings are often minimal, typically limited to pain and heightened sensitivity without significant redness or swelling. Systemic toxicity is more prominent and includes autonomic disturbances such as tachycardia, hypertension, sweating, agitation, and hyperthermia from sympathetic activation, as well as bradycardia, hypotension, and excessive salivation from parasympathetic effects. Neuromuscular symptoms include restlessness, involuntary muscle jerking, and severe agitation. Cranial nerve involvement may lead to abnormal eye movements, blurred vision, tongue fasciculations, and impaired swallowing or airway control.
Severity is classified into four grades. Mild cases (grades I and II) involve only local or regional symptoms, while severe envenomation (grades III and IV) includes neuromuscular dysfunction and combined autonomic and cranial nerve involvement. Severe cases may progress to respiratory compromise, requiring urgent intervention.
Diagnosis is clinical and based on symptom recognition, especially in endemic areas. Identification of the scorpion is not necessary. Laboratory tests are generally not required for mild cases but may be indicated in severe envenomation to assess complications such as electrolyte imbalance, renal injury, or rhabdomyolysis. Imaging and ECG may be used when cardiopulmonary symptoms are present.
Management begins with stabilization of airway, breathing, and circulation. Oxygen and intravenous access should be established early. Mild envenomations are treated with supportive care, including oral analgesics and tetanus prophylaxis. Severe envenomations require close monitoring and may necessitate airway protection, sedation (e.g., midazolam for agitation), and cardiovascular support.
Antivenom (Anascorp) is the definitive treatment for severe cases and works rapidly to reverse neurologic symptoms. It is administered intravenously, with initial dosing followed by reassessment and additional doses if needed. Importantly, the same dosing is used in both adults and children, as it is based on venom load rather than body weight.
Patients with severe envenomation should be admitted to an intensive care setting. Those who respond well to antivenom and remain stable after observation may be discharged with instructions regarding delayed reactions such as serum sickness. Mild cases can be safely discharged after a short observation period if symptoms do not progress.
A critical clinical point is maintaining a high index of suspicion in endemic regions, especially in children presenting with unexplained neurologic or autonomic symptoms. Early recognition and timely administration of antivenom can significantly reduce morbidity and prevent life-threatening complications.
Scorpion envenomation is a potentially serious condition caused by injection of neurotoxic venom, which affects sodium channels and leads to prolonged neuronal firing. This results in widespread stimulation of autonomic, somatic, and cranial nerves. Symptoms typically begin within minutes of the sting and can last from several hours up to 72 hours. The severity of illness varies depending on the species and the patient, with children at significantly higher risk of severe toxicity and complications.
The most clinically significant species in North America is Centruroides sculpturatus (bark scorpion), found in parts of the southern United States, Mexico, and Central America. Globally, many dangerous species exist across Asia, Africa, the Middle East, and South America. Pediatric patients are especially vulnerable due to lower body mass and may present with symptoms that mimic seizures, poisoning, or central nervous system infections.
Clinical manifestations develop rapidly, usually peaking within 1–2 hours. Local findings are often minimal, typically limited to pain and heightened sensitivity without significant redness or swelling. Systemic toxicity is more prominent and includes autonomic disturbances such as tachycardia, hypertension, sweating, agitation, and hyperthermia from sympathetic activation, as well as bradycardia, hypotension, and excessive salivation from parasympathetic effects. Neuromuscular symptoms include restlessness, involuntary muscle jerking, and severe agitation. Cranial nerve involvement may lead to abnormal eye movements, blurred vision, tongue fasciculations, and impaired swallowing or airway control.
Severity is classified into four grades. Mild cases (grades I and II) involve only local or regional symptoms, while severe envenomation (grades III and IV) includes neuromuscular dysfunction and combined autonomic and cranial nerve involvement. Severe cases may progress to respiratory compromise, requiring urgent intervention.
Diagnosis is clinical and based on symptom recognition, especially in endemic areas. Identification of the scorpion is not necessary. Laboratory tests are generally not required for mild cases but may be indicated in severe envenomation to assess complications such as electrolyte imbalance, renal injury, or rhabdomyolysis. Imaging and ECG may be used when cardiopulmonary symptoms are present.
Management begins with stabilization of airway, breathing, and circulation. Oxygen and intravenous access should be established early. Mild envenomations are treated with supportive care, including oral analgesics and tetanus prophylaxis. Severe envenomations require close monitoring and may necessitate airway protection, sedation (e.g., midazolam for agitation), and cardiovascular support.
Antivenom (Anascorp) is the definitive treatment for severe cases and works rapidly to reverse neurologic symptoms. It is administered intravenously, with initial dosing followed by reassessment and additional doses if needed. Importantly, the same dosing is used in both adults and children, as it is based on venom load rather than body weight.
Patients with severe envenomation should be admitted to an intensive care setting. Those who respond well to antivenom and remain stable after observation may be discharged with instructions regarding delayed reactions such as serum sickness. Mild cases can be safely discharged after a short observation period if symptoms do not progress.
A critical clinical point is maintaining a high index of suspicion in endemic regions, especially in children presenting with unexplained neurologic or autonomic symptoms. Early recognition and timely administration of antivenom can significantly reduce morbidity and prevent life-threatening complications.
0 Comments
